B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) Used for the Treatment of a Persistent Great Periapical Lesion of an Endodontically Treated Tooth: A New Therapeutic Option
The aim of this case report was to evaluate the efficacy of a new platelet-rich plasma preparation and its regenerative capacity of bone periapical tissue for the treatment of a very compromised endodontic treated tooth, with a periapical lesion of 1.5 cm in diameter, using a pure platelet concentra...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Dentistry |
| Online Access: | http://dx.doi.org/10.1155/2020/4876437 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832547693168164864 |
|---|---|
| author | Raffaello Viganò Mirko Disconzi Edoardo Bertini Luca Viganò Cinzia Casu |
| author_facet | Raffaello Viganò Mirko Disconzi Edoardo Bertini Luca Viganò Cinzia Casu |
| author_sort | Raffaello Viganò |
| collection | DOAJ |
| description | The aim of this case report was to evaluate the efficacy of a new platelet-rich plasma preparation and its regenerative capacity of bone periapical tissue for the treatment of a very compromised endodontic treated tooth, with a periapical lesion of 1.5 cm in diameter, using a pure platelet concentrate. This is made without the use of anticoagulant or any type of activator, e.g., bovine thrombin, calcium chloride. For this reason, it has been called “Pure”; it is the B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) designed and developed by Dr. Raffaello Viganò. The patient has read and signed a written consent form. The study protocol was approved by the Ethics Committee for Human Studies, University of Varese. X-ray at 2 and 6 months and 4 years after endodontic surgery demonstrated the success of the treatment. |
| format | Article |
| id | doaj-art-3072e023a874430185e712ee6ec51bc1 |
| institution | Kabale University |
| issn | 2090-6447 2090-6455 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Dentistry |
| spelling | doaj-art-3072e023a874430185e712ee6ec51bc12025-02-03T06:43:44ZengWileyCase Reports in Dentistry2090-64472090-64552020-01-01202010.1155/2020/48764374876437B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) Used for the Treatment of a Persistent Great Periapical Lesion of an Endodontically Treated Tooth: A New Therapeutic OptionRaffaello Viganò0Mirko Disconzi1Edoardo Bertini2Luca Viganò3Cinzia Casu4DDS, Freelancer in Varese, ItalyUniversity of Milano, Milano, ItalyUniversity of Milano, Milano, ItalyDepartment of Oral Radiology, San Paolo Dental Building, University of Milano, Milano, ItalyPrivate Dental Practice, Cagliari, ItalyThe aim of this case report was to evaluate the efficacy of a new platelet-rich plasma preparation and its regenerative capacity of bone periapical tissue for the treatment of a very compromised endodontic treated tooth, with a periapical lesion of 1.5 cm in diameter, using a pure platelet concentrate. This is made without the use of anticoagulant or any type of activator, e.g., bovine thrombin, calcium chloride. For this reason, it has been called “Pure”; it is the B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) designed and developed by Dr. Raffaello Viganò. The patient has read and signed a written consent form. The study protocol was approved by the Ethics Committee for Human Studies, University of Varese. X-ray at 2 and 6 months and 4 years after endodontic surgery demonstrated the success of the treatment.http://dx.doi.org/10.1155/2020/4876437 |
| spellingShingle | Raffaello Viganò Mirko Disconzi Edoardo Bertini Luca Viganò Cinzia Casu B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) Used for the Treatment of a Persistent Great Periapical Lesion of an Endodontically Treated Tooth: A New Therapeutic Option Case Reports in Dentistry |
| title | B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) Used for the Treatment of a Persistent Great Periapical Lesion of an Endodontically Treated Tooth: A New Therapeutic Option |
| title_full | B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) Used for the Treatment of a Persistent Great Periapical Lesion of an Endodontically Treated Tooth: A New Therapeutic Option |
| title_fullStr | B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) Used for the Treatment of a Persistent Great Periapical Lesion of an Endodontically Treated Tooth: A New Therapeutic Option |
| title_full_unstemmed | B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) Used for the Treatment of a Persistent Great Periapical Lesion of an Endodontically Treated Tooth: A New Therapeutic Option |
| title_short | B.P.F.C.® Bio-Plasma® with Pure Growth Factors (BioPlasma®) Used for the Treatment of a Persistent Great Periapical Lesion of an Endodontically Treated Tooth: A New Therapeutic Option |
| title_sort | b p f c r bio plasma r with pure growth factors bioplasma r used for the treatment of a persistent great periapical lesion of an endodontically treated tooth a new therapeutic option |
| url | http://dx.doi.org/10.1155/2020/4876437 |
| work_keys_str_mv | AT raffaellovigano bpfcbioplasmawithpuregrowthfactorsbioplasmausedforthetreatmentofapersistentgreatperiapicallesionofanendodonticallytreatedtoothanewtherapeuticoption AT mirkodisconzi bpfcbioplasmawithpuregrowthfactorsbioplasmausedforthetreatmentofapersistentgreatperiapicallesionofanendodonticallytreatedtoothanewtherapeuticoption AT edoardobertini bpfcbioplasmawithpuregrowthfactorsbioplasmausedforthetreatmentofapersistentgreatperiapicallesionofanendodonticallytreatedtoothanewtherapeuticoption AT lucavigano bpfcbioplasmawithpuregrowthfactorsbioplasmausedforthetreatmentofapersistentgreatperiapicallesionofanendodonticallytreatedtoothanewtherapeuticoption AT cinziacasu bpfcbioplasmawithpuregrowthfactorsbioplasmausedforthetreatmentofapersistentgreatperiapicallesionofanendodonticallytreatedtoothanewtherapeuticoption |